Dublin, April 16, 2026 (GLOBE NEWSWIRE) — The “China Healthcare Cold Chain Logistics Market Size and Share Analysis Report: Forecast Trends and Outlook (2025-2034)” has been added to ResearchAndMarkets.com’s offering. The report delves into market segmentation by service type, product type, temperature range, mode of transportation, and end-user categories.
The China healthcare cold chain logistics market, valued at USD 3.66 billion in 2024, is poised for significant growth, expecting a Compound Annual Growth Rate (CAGR) of 8.90% to reach USD 8.59 billion by 2034. This growth is driven by the rising biopharmaceutical manufacturing sector, stringent quality regulations, and increased vaccine distribution, bolstered by infrastructure modernization and cutting-edge temperature-controlled storage technologies.
Key Trends and Insights:
- China contributed approximately 4.4% of global market revenue historically.
- The biopharmaceutical segment dominated by accounting for 49% of total revenue.
- Storage services are forecasted to lead over the coming years.
Market Size and Forecast:
- 2024 Market Size: USD 3.66 Billion
- 2034 Projected Market Size: USD 8.59 Billion
- CAGR (2025-2034): 8.90%
The market’s robust growth is anchored by the expanding pharmaceutical and biotech sectors, with rising vaccine production and temperature-sensitive biologics fueling infrastructure investments. Regulatory standards ensure product safety, complemented by technological advances in temperature monitoring and transport systems. Government initiatives aimed at healthcare innovation further strengthen China’s position as a leader in secure, efficient cold chain distribution.
Growth Drivers
Expanding cold chain infrastructure and regulatory support are major growth drivers. Chinese government subsidies introduced in 2025 led to a significant increase in cold storage capacity. This capacity boost is in response to a growing demand for temperature-sensitive biologics, vaccines, and cell-based therapies. Investments from key players further enhance temperature integrity, essential for drug distribution.
Market Trends
China is shifting toward smart, sustainable logistical solutions, integrating advanced temperature-control systems and IoT-enabled monitoring. Companies employ real-time data tracking and predictive analytics, with Cold Chain Technologies significantly expanding its APAC presence, reflecting the demand for energy-efficient systems. This trend underlines China’s transition toward precision-based pharmaceutical cold chain operations.
Market Share
Biopharmaceuticals maintain a dominant position, attributed to increased demand for temperature-sensitive products and expanded biopharmaceutical manufacturing capacities. Infrastructure advancements and logistics technology continue to support this segment’s growth.
Leading Players
Significant players shaping the market include Cardinal Health, DHL Supply Chain, UPS Healthcare, FedEx Logistics, and others. These companies offer comprehensive solutions to ensure safe, compliant transportation of pharmaceuticals and biologics.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2025-2034 |
| Estimated Market Value (USD) in 2025 | $3.66 Billion |
| Forecasted Market Value (USD) by 2034 | $8.59 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | China |
For more information about this report visit https://www.researchandmarkets.com/r/uchcf7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Chinese Healthcare Cold Chain Logistics Market
